Fungal nail disease (Onychomycosis); Challenges and solutions

Onychomycosis (fungal nail infection) is caused by three groups of fungal pathogens namely dermatophyte molds (DM), non-DM (NDM) and yeasts. It is primarily a cosmetic problem but may induce impact on quality of life. Clinically it is characterized by five morphologically distinctive types; distal l...

Full description

Bibliographic Details
Main Authors: M. Suchitra Shenoy, M. Manjunath Shenoy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Archives of Medicine and Health Sciences
Subjects:
Online Access:http://www.amhsjournal.org/article.asp?issn=2321-4848;year=2014;volume=2;issue=1;spage=48;epage=53;aulast=Shenoy
_version_ 1828519973562089472
author M. Suchitra Shenoy
M. Manjunath Shenoy
author_facet M. Suchitra Shenoy
M. Manjunath Shenoy
author_sort M. Suchitra Shenoy
collection DOAJ
description Onychomycosis (fungal nail infection) is caused by three groups of fungal pathogens namely dermatophyte molds (DM), non-DM (NDM) and yeasts. It is primarily a cosmetic problem but may induce impact on quality of life. Clinically it is characterized by five morphologically distinctive types; distal lateral subungual onychomycosis (DLSO), superficial white onychomycosis (SWO), proximal subungual onychomycosis (PSO), and endothrix onychomycosis. It is difficult to detect the fungal agent responsible for a particular type of onychomycosis by clinical features alone. Mycological methods like direct demonstration of fungal agents by potassium hydroxide mount or nail plate histopathology with Periodic acid Schiff (PAS) staining are sensitive methods for the detection of pathogens. Fungal culture alone is commonly used as a standard for the detection of etiological agent. Molecular biological techniques are currently used only in research laboratories or epidemiological purposes. Therapy is generally not satisfactory. Both topical and systemic agents are used in the therapy. Topical Ciclopirix and Amorolfine are found to be effective but only in early and limited disease. Terbinafine and Itraconazole seems to be the best drugs for the systemic therapy. Clinical cure rates are generally lower than the mycological cure rates.
first_indexed 2024-12-11T19:21:31Z
format Article
id doaj.art-f09571e245ca4e518197111e65328c9d
institution Directory Open Access Journal
issn 2321-4848
language English
last_indexed 2024-12-11T19:21:31Z
publishDate 2014-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Archives of Medicine and Health Sciences
spelling doaj.art-f09571e245ca4e518197111e65328c9d2022-12-22T00:53:30ZengWolters Kluwer Medknow PublicationsArchives of Medicine and Health Sciences2321-48482014-01-0121485310.4103/2321-4848.133811Fungal nail disease (Onychomycosis); Challenges and solutionsM. Suchitra ShenoyM. Manjunath ShenoyOnychomycosis (fungal nail infection) is caused by three groups of fungal pathogens namely dermatophyte molds (DM), non-DM (NDM) and yeasts. It is primarily a cosmetic problem but may induce impact on quality of life. Clinically it is characterized by five morphologically distinctive types; distal lateral subungual onychomycosis (DLSO), superficial white onychomycosis (SWO), proximal subungual onychomycosis (PSO), and endothrix onychomycosis. It is difficult to detect the fungal agent responsible for a particular type of onychomycosis by clinical features alone. Mycological methods like direct demonstration of fungal agents by potassium hydroxide mount or nail plate histopathology with Periodic acid Schiff (PAS) staining are sensitive methods for the detection of pathogens. Fungal culture alone is commonly used as a standard for the detection of etiological agent. Molecular biological techniques are currently used only in research laboratories or epidemiological purposes. Therapy is generally not satisfactory. Both topical and systemic agents are used in the therapy. Topical Ciclopirix and Amorolfine are found to be effective but only in early and limited disease. Terbinafine and Itraconazole seems to be the best drugs for the systemic therapy. Clinical cure rates are generally lower than the mycological cure rates.http://www.amhsjournal.org/article.asp?issn=2321-4848;year=2014;volume=2;issue=1;spage=48;epage=53;aulast=ShenoyOnychomycosisdermatophytefungal cultureterbinafine
spellingShingle M. Suchitra Shenoy
M. Manjunath Shenoy
Fungal nail disease (Onychomycosis); Challenges and solutions
Archives of Medicine and Health Sciences
Onychomycosis
dermatophyte
fungal culture
terbinafine
title Fungal nail disease (Onychomycosis); Challenges and solutions
title_full Fungal nail disease (Onychomycosis); Challenges and solutions
title_fullStr Fungal nail disease (Onychomycosis); Challenges and solutions
title_full_unstemmed Fungal nail disease (Onychomycosis); Challenges and solutions
title_short Fungal nail disease (Onychomycosis); Challenges and solutions
title_sort fungal nail disease onychomycosis challenges and solutions
topic Onychomycosis
dermatophyte
fungal culture
terbinafine
url http://www.amhsjournal.org/article.asp?issn=2321-4848;year=2014;volume=2;issue=1;spage=48;epage=53;aulast=Shenoy
work_keys_str_mv AT msuchitrashenoy fungalnaildiseaseonychomycosischallengesandsolutions
AT mmanjunathshenoy fungalnaildiseaseonychomycosischallengesandsolutions